Search research articles
Contact Us
Filters
Showing results (621-630 of 636) with videos related to
Page
of 64
Sort By:
ISME Communications
|
September 2, 2025
Upcycling human excrement: the gut microbiome to soil microbiome axis
Jeff Meilander, Chloe Herman, Andrew Manley, et al.
European Heart Journal
|
January 6, 2026
Endothelial ZBTB16: a molecular shield against cardiac aging
Kathrin A Stilz, Vincent Elvin Leonard, David Rodriguez Morales, et al.
Circulation Research
|
July 30, 2025
Immunoregulatory Endothelial Cells Interact With T Cells After Myocardial Infarction
Lukas S Tombor, Till Lautenschläger, Simone F Glaser, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 8, 2017
A craniosynostosis massively parallel sequencing panel study in 309 Australian and New Zealand patients: findings and recommendations
Eric Lee, Trang Le, Ying Zhu, et al.
Neurology
|
August 20, 2025
Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis
Isabel Charlotte Hostettler, Ana Ponciano, Duncan Wilson, et al.
Blood Advances
|
January 16, 2026
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN Study
Krish Patel, Julie M Vose, Sunita D Nasta, et al.
Journal of Neurology
|
July 17, 2021
Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis
Isabel Charlotte Hostettler, Duncan Wilson, Catherine Arnold Fiebelkorn, et al.
JAMA
|
December 21, 2021
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll, et al.
JAMA
|
May 4, 2021
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
Silje Watterdal Syversen, Guro Løvik Goll, Kristin Kaasen Jørgensen, et al.
BMJ (Clinical Research Ed.)
|
December 3, 2020
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
Merete Lund Hetland, Espen A Haavardsholm, Anna Rudin, et al.
Page
of 64
Search research articles
Search
Showing results (621-630 of 636) with videos related to
Sort By:
Page
of 64
ISME Communications
|
September 2, 2025
Upcycling human excrement: the gut microbiome to soil microbiome axis
Jeff Meilander, Chloe Herman, Andrew Manley, et al.
European Heart Journal
|
January 6, 2026
Endothelial ZBTB16: a molecular shield against cardiac aging
Kathrin A Stilz, Vincent Elvin Leonard, David Rodriguez Morales, et al.
Circulation Research
|
July 30, 2025
Immunoregulatory Endothelial Cells Interact With T Cells After Myocardial Infarction
Lukas S Tombor, Till Lautenschläger, Simone F Glaser, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 8, 2017
A craniosynostosis massively parallel sequencing panel study in 309 Australian and New Zealand patients: findings and recommendations
Eric Lee, Trang Le, Ying Zhu, et al.
Neurology
|
August 20, 2025
Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis
Isabel Charlotte Hostettler, Ana Ponciano, Duncan Wilson, et al.
Blood Advances
|
January 16, 2026
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN Study
Krish Patel, Julie M Vose, Sunita D Nasta, et al.
Journal of Neurology
|
July 17, 2021
Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis
Isabel Charlotte Hostettler, Duncan Wilson, Catherine Arnold Fiebelkorn, et al.
JAMA
|
December 21, 2021
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll, et al.
JAMA
|
May 4, 2021
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
Silje Watterdal Syversen, Guro Løvik Goll, Kristin Kaasen Jørgensen, et al.
BMJ (Clinical Research Ed.)
|
December 3, 2020
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
Merete Lund Hetland, Espen A Haavardsholm, Anna Rudin, et al.
Page
of 64